Cargando…

Evolocumab attenuate pericoronary adipose tissue density via reduction of lipoprotein(a) in type 2 diabetes mellitus: a serial follow-up CCTA study

BACKGROUND: Pericoronary adipose tissue (PCAT) density is a biomarker of vessel inflammation, which is supposed to be increased in patients with type 2 diabetes mellitus (T2DM). However, whether the coronary inflammation revealed by this novel index could be alleviated after evolocumab treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Meng-Meng, Zhao, Xin, Chen, Yin-Yin, Tao, Xin-Wei, Ge, Jun-Bo, Jin, Hang, Zeng, Meng-Su
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204214/ https://www.ncbi.nlm.nih.gov/pubmed/37217967 http://dx.doi.org/10.1186/s12933-023-01857-w

Ejemplares similares

Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction
por: Henry, Courtney A, et al.
Publicado: (2016)

Evaluation of pericoronary adipose tissue attenuation on CT
por: Ma, Runlei, et al.
Publicado: (2023)

Pericoronary Adipose Tissue as Storage and Supply Site for Oxidized Low-Density Lipoprotein in Human Coronary Plaques
por: Uchida, Yasumi, et al.
Publicado: (2016)

Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab
por: Desai, Nihar R., et al.
Publicado: (2021)

Serial Assessment of Pericoronary Adipose Tissue Inflammation in a Patient With MINOCA Potentially Complicated With Vasospasm
por: Horie, Tomoki, et al.
Publicado: (2020)

Relationship Between Low‐Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab
por: Shapiro, Michael D., et al.
Publicado: (2019)

Determinants of Pericoronary Adipose Tissue Attenuation on Computed Tomography Angiography in Coronary Artery Disease
por: Sugiyama, Tomoyo, et al.
Publicado: (2020)

Impact of pericoronary adipose tissue attenuation on recurrence after radiofrequency catheter ablation for atrial fibrillation
por: Wang, Zhe, et al.
Publicado: (2023)

Pericoronary and periaortic adipose tissue density are associated with inflammatory disease activity in Takayasu arteritis and atherosclerosis
por: Wall, Christopher, et al.
Publicado: (2021)

Evolocumab Effects on Lipoproteins, Measured by High-Performance Liquid Chromatography
por: Masuda, Daisaku, et al.
Publicado: (2020)

Pericoronary Adipose Tissue Attenuation in Patients With Acute Coronary Syndrome Versus Stable Coronary Artery Disease
por: Kuneman, Jurrien H., et al.
Publicado: (2023)

Influence of Different Segmentations on the Diagnostic Performance of Pericoronary Adipose Tissue
por: Wen, Didi, et al.
Publicado: (2022)

Efficacy and safety of different doses of evolocumab in reducing low-density lipoprotein cholesterol levels: A meta-analysis
por: Cheng, Cheng, et al.
Publicado: (2016)

Focal pericoronary adipose tissue attenuation is related to plaque presence, plaque type, and stenosis severity in coronary CTA
por: Ma, Runlei, et al.
Publicado: (2021)

Vessel and sex differences in pericoronary adipose tissue attenuation obtained with coronary CT in individuals without coronary atherosclerosis
por: van Rosendael, Sophie E., et al.
Publicado: (2022)

Towards universal comparability of pericoronary adipose tissue attenuation: a coronary computed tomography angiography phantom study
por: Etter, Dominik, et al.
Publicado: (2022)

Characterization of plaque phenotypes exhibiting an elevated pericoronary adipose tissue attenuation: insights from the REASSURE-NIRS registry
por: Kitahara, Satoshi, et al.
Publicado: (2023)

Pericoronary adipose tissue attenuation on coronary computed tomography angiography associates with male sex and Indigenous Australian status
por: Yuvaraj, Jeremy, et al.
Publicado: (2023)

Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level
por: Afanasieva, Olga, et al.
Publicado: (2020)

Association between High Pericoronary Adipose Tissue Computed Tomography Attenuation and Impaired Flow-Mediated Dilation of the Brachial Artery
por: Ichikawa, Keishi, et al.
Publicado: (2023)

Computed tomography–based pericoronary adipose tissue attenuation in patients undergoing TAVR: a novel method for risk assessment
por: Steyer, Alexandra, et al.
Publicado: (2023)

Effect of Evolocumab on Non‐High‐Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a): A Pooled Analysis of Phase 2 and Phase 3 Studies
por: Toth, Peter P., et al.
Publicado: (2020)

Atherosclerosis Pathways are Activated in Pericoronary Adipose Tissue of Patients with Coronary Artery Disease
por: Konwerski, Michał, et al.
Publicado: (2021)

The correlation of pericoronary adipose tissue with coronary artery disease and left ventricular function
por: You, Deshu, et al.
Publicado: (2022)

Predicting coronary atherosclerosis heart disease with pericoronary adipose tissue attenuation parameters based on dual-layer spectral detector computed tomography: a preliminary exploration
por: Zou, Lei, et al.
Publicado: (2023)

Two Patients with Familial Hypercholesterolemia Who Were Successfully Weaned from Low-density Lipoprotein Apheresis after Treatment with Evolocumab
por: Tanaka, Akihito, et al.
Publicado: (2017)

Non-contrast CT-based radiomics nomogram of pericoronary adipose tissue for predicting haemodynamically significant coronary stenosis in patients with type 2 diabetes
por: Chen, Can, et al.
Publicado: (2023)

Towards reference values of pericoronary adipose tissue attenuation: impact of coronary artery and tube voltage in coronary computed tomography angiography
por: Ma, Runlei, et al.
Publicado: (2020)

Effect of Evolocumab on Vulnerable Coronary Plaques: A Serial Coronary Computed Tomography Angiography Study
por: Hirai, Keiji, et al.
Publicado: (2020)

Acute Effect of Evolocumab on Lipoprotein(a) Level and Inflammation in Patients with Coronary Artery Disease
por: Choi, Seung Woo, et al.
Publicado: (2022)

Development of artificial intelligence in epicardial and pericoronary adipose tissue imaging: a systematic review
por: Zhang, Lu, et al.
Publicado: (2021)

The Effect of Clinically Indicated Liraglutide on Pericoronary Adipose Tissue in Type 2 Diabetic Patients
por: Biesenbach, Irmelin I. A., et al.
Publicado: (2023)

Exploring the Efficacy of Alirocumab and Evolocumab in Reducing Low-Density Lipoprotein (LDL) Cholesterol Levels in Patients With Familial Hypercholesterolemia: A Systematic Review
por: Luthra, Gaurav, et al.
Publicado: (2022)

Pericoronary Fat Attenuation Index Is Associated With Vulnerable Plaque Components and Local Immune‐Inflammatory Activation in Patients With Non‐ST Elevation Acute Coronary Syndrome
por: Sun, Jia Teng, et al.
Publicado: (2022)

Pericoronary Adipose Tissue Attenuation Is Associated with High-Risk Plaque and Subsequent Acute Coronary Syndrome in Patients with Stable Coronary Artery Disease
por: Yuvaraj, Jeremy, et al.
Publicado: (2021)

Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia)
por: Waldmann, Elisa, et al.
Publicado: (2022)

Coronary Inflammation by Computed Tomography Pericoronary Fat Attenuation in MINOCA and Tako‐Tsubo Syndrome
por: Gaibazzi, Nicola, et al.
Publicado: (2019)

Maximal pericoronary adipose tissue thickness is associated with hypertension in nonobese patients with acute or chronic illness
por: Chang, Shinhae, et al.
Publicado: (2017)

Pericoronary Adipose Tissue Radiomics from Coronary Computed Tomography Angiography Identifies Vulnerable Plaques
por: Kim, Justin N., et al.
Publicado: (2023)

High pericoronary adipose tissue attenuation on computed tomography angiography predicts cardiovascular events in patients with type 2 diabetes mellitus: post-hoc analysis from a prospective cohort study
por: Ichikawa, Keishi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_topc38uemq00qjqrh3105ag6q6